Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Net Margin: 2023-2024

Historic Net Margin for Artiva Biotherapeutics (ARTV) over the last 1 years, with Mar 2024 value amounting to -5,514.74%.

  • Artiva Biotherapeutics' Net Margin was N/A to -5,514.74% in Q1 2024 from the same period last year, while for Mar 2024 it was -101.38%, marking a year-over-year change of. This contributed to the annual value of -26,045.02% for FY2024, which is 2595927.00% down from last year.
  • Per Artiva Biotherapeutics' latest filing, its Net Margin stood at -5,514.74% for Q1 2024, which was down 1,038.11% from -484.55% recorded in Q4 2023.
  • Over the past 5 years, Artiva Biotherapeutics' Net Margin peaked at 42.13% during Q3 2023, and registered a low of -5,514.74% during Q1 2024.
  • For the 2-year period, Artiva Biotherapeutics' Net Margin averaged around -1,910.07%, with its median value being -1,083.84% (2023).